Sherman, S. et al. 2019. IL-17A Inhibitor Switching – Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience. Acta Dermato-Venereologica. 99, 9 (May 2019), 769–773. DOI:https://doi.org/10.2340/00015555-3200.